180 related articles for article (PubMed ID: 32639290)
1. Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
Caroff SN; Leong SH; Roberts CB; Berkowitz RM; Campbell EC
J Clin Psychopharmacol; 2020; 40(4):373-380. PubMed ID: 32639290
[TBL] [Abstract][Full Text] [Related]
2. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
[TBL] [Abstract][Full Text] [Related]
3. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
[TBL] [Abstract][Full Text] [Related]
4. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.
McEvoy J; Gandhi SK; Rizio AA; Maher S; Kosinski M; Bjorner JB; Carroll B
Qual Life Res; 2019 Dec; 28(12):3303-3312. PubMed ID: 31435866
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis.
Patterson-Lomba O; Ayyagari R; Carroll B
BMC Neurol; 2019 Jul; 19(1):174. PubMed ID: 31325958
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF
Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342
[TBL] [Abstract][Full Text] [Related]
7. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
Farber RH; Stull DE; Witherspoon B; Evans CJ; Yonan C; Bron M; Dhanda R; Jen E; Brien CO'
J Patient Rep Outcomes; 2024 Jan; 8(1):2. PubMed ID: 38175450
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
Correll CU; Josiassen RC; Liang GS; Burke J; O'Brien CF
Psychopharmacol Bull; 2017 Aug; 47(3):53-60. PubMed ID: 28839340
[TBL] [Abstract][Full Text] [Related]
9. Frequency and correlates of tardive dyskinesia in Indian patients with type I bipolar disorder.
Rajan TM; Bharadwaj B; Rajkumar RP; Adole PS
Asian J Psychiatr; 2018 Feb; 32():92-98. PubMed ID: 29222987
[TBL] [Abstract][Full Text] [Related]
10. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
McEvoy J; Park T; Schilling T; Terasawa E; Ayyagari R; Carroll B
Curr Med Res Opin; 2019 Jul; 35(7):1205-1214. PubMed ID: 30638073
[No Abstract] [Full Text] [Related]
11. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia.
Uludag K; Wang DM; Goodman C; Chen DC; Wang L; Zhang X
Asian J Psychiatr; 2021 Dec; 66():102877. PubMed ID: 34638091
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
[TBL] [Abstract][Full Text] [Related]
13. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Stacy M; Sajatovic M; Kane JM; Cutler AJ; Liang GS; O'Brien CF; Correll CU
Mov Disord; 2019 Aug; 34(8):1203-1209. PubMed ID: 31234240
[TBL] [Abstract][Full Text] [Related]
14. Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement.
Yu T; Li Y; Fan F; Cao H; Luo X; Tan S; Yang F; Zhang X; Shugart YY; Hong LE; Li CR; Tan Y
Sci Rep; 2018 Aug; 8(1):12884. PubMed ID: 30150749
[TBL] [Abstract][Full Text] [Related]
15. RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.
Caroff SN; Yeomans K; Lenderking WR; Cutler AJ; Tanner CM; Shalhoub H; Pagé V; Chen J; Franey E; Yonan C
J Clin Psychopharmacol; 2020; 40(3):259-268. PubMed ID: 32332461
[TBL] [Abstract][Full Text] [Related]
16. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
Preskorn SH; Macaluso M
J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
Caroff SN; Davis VG; Miller DD; Davis SM; Rosenheck RA; McEvoy JP; Campbell EC; Saltz BL; Riggio S; Chakos MH; Swartz MS; Keefe RS; Stroup TS; Lieberman JA;
J Clin Psychiatry; 2011 Mar; 72(3):295-303. PubMed ID: 20816031
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study.
Nagano M; Susuta Y; Masui H; Watanabe Y; Watanabe K
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):107-116. PubMed ID: 38421921
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
20. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
